Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMI:TSE International Medical Innovations Inc. -- Ignore unavailable to you. Want to Upgrade?

To: gg cox who wrote (37)	12/2/2003 10:56:15 AM
From: gg cox	Read Replies (1) \| Respond to of 66

Webcast Notification: IMI International Medical Innovations Inc. - Presentation At The American Stock Exchange Online Conference - December 3, 2003 Tuesday December 2, 10:00 am ET TORONTO, Dec. 2 /CNW/ - Webcast Notification: IMI International Medical Innovations Inc. - Presentation At The American Stock Exchange Online Conference IMI International Medical Innovations Inc. AMEX: IME, TSX: IMI. Presentation At The American Stock Exchange Online Conference December 03, 2003, 10:30 EST To listen to this event: firstcallevents.com About IMI IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases, particularly cardiovascular disease and cancer. The company's lead product is the world's first non-invasive cholesterol test system. IMI is also developing a suite of screening tests for cancer, including ColorectAlert for colorectal cancer, LungAlert for lung cancer, and a new test for early-stage breast cancer. For further information, please visit the company's web site at www.imimedical.com. Company Web site: www.imimedical.com newswire.ca For further information Andrew Weir, (416) 222-3449, aweir@imimedical.com -------------------------------------------------------------------------------- Source: IMI International Medical Innovations Inc.